Breast Medical Oncologist/Director of Breast Cancer Clinical Research/Phase 1 Novel Therapeutics/Mom of princesses:human daughters and golden doodle/yogi
I am grateful to the V Foundation for this award. I look forward to contributing to the Mission of the Foundation in this important endeavor to increase Clinical Trial participation of Black women with Breast Cancer.@RutgersCancer@TheVFoundation
I've been part of @ASCO for years, but our work has never been a major part of a Clinical Science Symposium. This project is very important to me as it is our first publication in gender equity research. It also allowed me to bring together colleagues old and new.
Our chief fellow Jess Caro from @Perlmutter_CC will take it away 9:48 am 6/6 in E350, but come at 9 for the whole session."Aspirations of Equity In Oncology" chaired by @fumikochino and Jaydira Del Rivero. It's about about creating opportunities for equity at the end of the day.
A thanks to @LealTiciana@nancychan29@marina_sharifi and all the pts. Carbo/taxol + talazoparib is feasible but with cytopenias. A phase I study of talazoparib with carboplatin/ paclitaxel in advanced solid tumors (NCI9782) https://t.co/rdwoAYPLGo
Delighted that our original work has been accepted for oral presentation in a Clinical Science Symposium entitled “Aspirations of Equity in Oncology” at ASCO. Will post details as the meeting gets closer. Best part was many great collaborators. @PamelaKunzMD@kspencer725
Lung cancer screening saves lives. A perfect example is the work done by Dr Elaine Shum. Congrats on being recognized tonight @Perlmutter_CC@nyulangone @LUNGFORCE @ElaineShumMD
We would like to give warm welcome to
@LindaVahdat the new Chief of hematology/oncology section @CancerDartmouth; We are happy to have you and look forward to fruitful clinical and research collaborations @DartmouthHitch@DartmouthHemOnc
Congrats to medical oncologist Dr. Janice Mehnert, @JaniceM10 for her appointment as the new co-chair of the @eaonc#melanoma committee.
Learn more: https://t.co/dwmQSieZWT
We are pleased to announce that @KariWisinski_MD has been named permanent Chief of @uw_hemeoncpc!
Her vision for the division includes
🏥 improving clinical operations
⬆️ increasing enrollment in interventional clinical trials
🤝 supporting wellness and DEI efforts
Medical oncologist Dr. Janice Mehnert @JaniceM10 opened a trial to study safe combination doses and preliminary safety and efficacy for three monoclonal antibody investigational drugs in participants with advanced malignancies.
Lean more: https://t.co/965I6IW5F3